Bristol Myers Squibb followed Merck’s steps and filed suit against the Inflation Reduction Act’s upcoming allowance for Medicare to negotiate with drugmakers over their most expensive products, according to court documents.
Read the full post on Becker's Hospital Review - Healthcare News
